Skip to main content
Nicholas Allen

Professor Nicholas Allen

Professor

School of Biosciences

Email
AllenND@cardiff.ac.uk
Telephone
+44 29208 76196
Campuses
Sir Martin Evans Building, Museum Avenue, Cardiff, CF10 3AX

Publication

2023

2022

2021

2020

2019

2018

2017

2016

2015

2013

2012

2011

2010

2009

2008

2007

2006

2005

2004

2003

2002

2001

Articles

Research

Current Research

Human IPSC models of neurodegenerative disease

Neurodegenerative diseases are devastating for patients, families and society. Understanding the mechanistic basis of these diseases is fundamental to future drug development and therapeutic intervention. My group works on two diseases – Huntington’s (HD) and Alzheimer’s (AD). HD is an inherited genetic disorder caused by mutation in a single gene called huntingtin (Htt), in contrast AD is a multifactorial disease with a significant degree of risk gene heritability.  A major research challenge is to model these diseases, to gain an understanding of disease mechanisms and to build platforms for future drug discovery and testing. To address this challenge my research group has focussed on the development of human cell models of disease. We take advantage of landmark ‘induced pluripotent stem cell technologies’ that ultimately enable disease models to be derived from patients – thereby directly integrating patient genetics into the models.

My group has longstanding expertise in developmental neuroscience and stem cell biology. We harness this expertise to control stem cell differentiation to generate highly defined disease models that comprise the most disease–relevant cells for study. We collaborate extensively working within consortia for HD disease modeling (NINDS/CHDI HD iPS Consortium) and cell therapy (FP7 Repair HD) and for AD in the MRC/Dementia Platform UK (DPUK) stem cell network. For each program we provided expertise in stem cell differentiation, CRISPR-Cas9 genome editing and neurobiology. Our work on HD has led to novel biomarker discovery, provided progressive phenotyping, identified physiological deficits in the human neuronal models and led to engagement with industry to translate platforms for drug discovery.

Current grant support

  • MRC
  • EU FP7
  • GW4
  • Wellcome Trust

Collaborators

  • Prof Paul Kemp
  • Prof Anne Rosser
  • Prof Lesley Jones
  • Dr Emyr Lloyd Evans
  • Prof Adrian Harwood
  • Prof James Uney (Bristol)
  • Prof  Siddharthan Chandran (Edinburgh)
  • Prof Richard Wade-Martins (Oxford)
  • Prof Nigel Hooper (Manchester)
  • Prof Tom Warner (UCL)
  • Prof Rick Livesey (Cambridge)
  • Prof Leslie Thompson (UCI,USA)

Affiliated staff

Postdocs

  • Dr Emma Cope
  • Dr Christain Schnell

PhD students

  • Aurelien Bunga
  • Jasmine Donaldson
  • Kimberley Jones
  • Nikki Buckner

Biography

Committees and reviewing